Rockwell Medical logo

Rockwell MedicalNASDAQ: RMTI

Profile

Sector:

Healthcare

Country:

United States

IPO:

27 January 1998

Next earnings report:

14 August 2024

Last dividends:

N/A

Next dividends:

N/A
$53.36 M
-69%vs. 3y high
36%vs. sector
-vs. 3y high
-vs. sector
-86%vs. 3y high
66%vs. sector
-73%vs. 3y high
15%vs. sector

Price

after hours | Wed, 03 Jul 2024 18:56:17 GMT
$1.76+$0.07(+4.14%)

Dividend

No data over the past 3 years
$22.68 M$22.92 M
$22.68 M-$1.73 M

Analysts recommendations

Institutional Ownership

RMTI Latest News

Rockwell Medical Promotes Tim Chole to Chief Commercial Officer
businesswire.com30 May 2024 Sentiment: POSITIVE

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Mr. Chole has played a key role in helping Rockwell Medical increase its market share and broaden its product portfolio.

Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research14 May 2024 Sentiment: POSITIVE

Rockwell Medical (RMTI) reported a quarterly loss of $0.02 per share, which was better than the expected loss of $0.05 per share according to the Zacks Consensus Estimate. This is an improvement from the loss of $0.10 per share reported in the same quarter last year.

Rockwell Medical (RMTI) Increases Despite Market Slip: Here's What You Need to Know
Zacks Investment Research26 March 2024 Sentiment: POSITIVE

In the latest trading session, Rockwell Medical (RMTI) closed at $1.65, marking a +1.85% move from the previous day.

Rockwell Medical (RMTI) Q4 Earnings and Revenues Beat Estimates
Zacks Investment Research21 March 2024 Sentiment: POSITIVE

Rockwell Medical (RMTI) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.08 per share. This compares to loss of $0.20 per share a year ago.

Rockwell Medical (RMTI) Rises As Market Takes a Dip: Key Facts
Zacks Investment Research11 March 2024 Sentiment: POSITIVE

Rockwell Medical (RMTI) concluded the recent trading session at $1.54, signifying a +1.32% move from its prior day's close.

Rockwell Medical (RMTI) Ascends While Market Falls: Some Facts to Note
Zacks Investment Research05 March 2024 Sentiment: POSITIVE

In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.48, denoting a +0.68% change from the preceding trading day.

Rockwell Medical (RMTI) Flat As Market Gains: What You Should Know
Zacks Investment Research27 February 2024 Sentiment: NEUTRAL

In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.37, denoting no change from the preceding trading day.

Why Rockwell Medical (RMTI) Dipped More Than Broader Market Today
Zacks Investment Research20 February 2024 Sentiment: NEGATIVE

In the closing of the recent trading day, Rockwell Medical (RMTI) stood at $1.34, denoting a -0.74% change from the preceding trading day.

Rockwell Medical (RMTI) Flat As Market Gains: What You Should Know
Zacks Investment Research14 February 2024 Sentiment: NEUTRAL

Rockwell Medical (RMTI) closed at $1.29 in the latest trading session, marking no change from the prior day.

Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024
Business Wire08 February 2024 Sentiment: NEGATIVE

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the fourth quarter and full-year ended December 31, 2023 on Thursday, March 21, 2024.

  • 1(current)

What type of business is Rockwell Medical?

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

What sector is Rockwell Medical in?

Rockwell Medical is in the Healthcare sector

What industry is Rockwell Medical in?

Rockwell Medical is in the Drug Manufacturers - Specialty & Generic industry

What country is Rockwell Medical from?

Rockwell Medical is headquartered in United States

When did Rockwell Medical go public?

Rockwell Medical initial public offering (IPO) was on 27 January 1998

What is Rockwell Medical website?

https://www.rockwellmed.com

Is Rockwell Medical in the S&P 500?

No, Rockwell Medical is not included in the S&P 500 index

Is Rockwell Medical in the NASDAQ 100?

No, Rockwell Medical is not included in the NASDAQ 100 index

Is Rockwell Medical in the Dow Jones?

No, Rockwell Medical is not included in the Dow Jones index

When does Rockwell Medical report earnings?

The next expected earnings date for Rockwell Medical is 14 August 2024